Experiment 782102

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SHENGMANOL,24-O-ACETYL-HYDRO: XYLOSIDECIMICIFUGOSIDE H-1CIMIGEN-3-ONEACTEINCIMIGEN-3-15-DIONECIMIGENOL,12-BETA-HYDROXY:CIMIGENOL,15-DEOXY:SHENGMANOL,ACETYL: XYLOSIDECIMIGENOL XYLOSIDECIMICIFUGOSIDE H-4CIMIGENOL,7-BETA-HYDROXY:

Alerts

VS.12-O-TETRADECANOYLPHORBOL-13-ACETATE(TPA)-INDUCED EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION.

Details

PropertyValue
Pharmacology
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
OrganismEmpty organism
CitationSAKURAI,N: KOZUKA,M: TOKUDA,H: NOBUKUNI,Y: TAKAYASU,J: NISHINO,H: KUSANO,A: KUSANO,G: NAGAI,M: SAKURAI,Y: LEE,KH:. (2003). ANTITUMOR AGENTS. 220. ANTITUMOR-PROMOTING EFFECTS OF CIMIGENOL AND RELATED COMPOUNDS ON EPSTEIN-BARR VIRUS ACTIVATION AND TWO-STAGE MOUSE SKIN CARCINOGENESIS.. 11(6)
Amount utilized
Compound isolated
Dose amountVAR
Number3
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED